Cargando…

Critical-illness-Myopathie und -Polyneuropathie

An average of 50–80% of patients treated in the intensive care unit is affected by disturbances of neuromuscular functions due to damage to the nerves and muscles, which has led to the terms critical illness polyneuropathy and myopathy. Both components occur in 30–50% of patients, while the others p...

Descripción completa

Detalles Bibliográficos
Autores principales: Senger, D., Erbguth, F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Medizin 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7095927/
https://www.ncbi.nlm.nih.gov/pubmed/28875277
http://dx.doi.org/10.1007/s00063-017-0339-0
_version_ 1783510714146619392
author Senger, D.
Erbguth, F.
author_facet Senger, D.
Erbguth, F.
author_sort Senger, D.
collection PubMed
description An average of 50–80% of patients treated in the intensive care unit is affected by disturbances of neuromuscular functions due to damage to the nerves and muscles, which has led to the terms critical illness polyneuropathy and myopathy. Both components occur in 30–50% of patients, while the others predominantly show a pure myopathy, while pure neuropathy is rare. Meanwhile, the descriptive term of the concept as intensive care unit-acquired weakness (ICUAW) is preferred. The most significant risk factors for the development of ICUAW are sepsis, multiorgan dysfunction and acute respiratory distress syndrome (ARDS). In at least one third of patients, persistent impairment by paralysis, sensory disturbances and balance problems persist when they leave the ICU. At approximately 10%, these leg-accentuated and highly everyday relevant disorders persist over the first year after ICU therapy. Pure myopathy rarely leads to residual disturbances, while the neuropathic component is responsible for long-term impairments.
format Online
Article
Text
id pubmed-7095927
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Springer Medizin
record_format MEDLINE/PubMed
spelling pubmed-70959272020-03-26 Critical-illness-Myopathie und -Polyneuropathie Senger, D. Erbguth, F. Med Klin Intensivmed Notfmed Leitthema An average of 50–80% of patients treated in the intensive care unit is affected by disturbances of neuromuscular functions due to damage to the nerves and muscles, which has led to the terms critical illness polyneuropathy and myopathy. Both components occur in 30–50% of patients, while the others predominantly show a pure myopathy, while pure neuropathy is rare. Meanwhile, the descriptive term of the concept as intensive care unit-acquired weakness (ICUAW) is preferred. The most significant risk factors for the development of ICUAW are sepsis, multiorgan dysfunction and acute respiratory distress syndrome (ARDS). In at least one third of patients, persistent impairment by paralysis, sensory disturbances and balance problems persist when they leave the ICU. At approximately 10%, these leg-accentuated and highly everyday relevant disorders persist over the first year after ICU therapy. Pure myopathy rarely leads to residual disturbances, while the neuropathic component is responsible for long-term impairments. Springer Medizin 2017-09-05 2017 /pmc/articles/PMC7095927/ /pubmed/28875277 http://dx.doi.org/10.1007/s00063-017-0339-0 Text en © Springer Medizin Verlag GmbH 2017 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Leitthema
Senger, D.
Erbguth, F.
Critical-illness-Myopathie und -Polyneuropathie
title Critical-illness-Myopathie und -Polyneuropathie
title_full Critical-illness-Myopathie und -Polyneuropathie
title_fullStr Critical-illness-Myopathie und -Polyneuropathie
title_full_unstemmed Critical-illness-Myopathie und -Polyneuropathie
title_short Critical-illness-Myopathie und -Polyneuropathie
title_sort critical-illness-myopathie und -polyneuropathie
topic Leitthema
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7095927/
https://www.ncbi.nlm.nih.gov/pubmed/28875277
http://dx.doi.org/10.1007/s00063-017-0339-0
work_keys_str_mv AT sengerd criticalillnessmyopathieundpolyneuropathie
AT erbguthf criticalillnessmyopathieundpolyneuropathie